Search research articles
Contact Us
Filters
Showing results (351-360 of 546) with videos related to
Page
of 55
Sort By:
EJNMMI Research
|
August 18, 2017
O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres
Christian P Filss, Nathalie L Albert, Guido Böning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2018
Impact of <sup>68</sup>Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis
Nina-Sophie Schmidt-Hegemann, Chukwuka Eze, Minglun Li, et al.
Frontiers in Neuroscience
|
July 6, 2016
Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches
Adrien Holzgreve, Matthias Brendel, Song Gu, et al.
Neuroimage. Clinical
|
February 1, 2017
Evaluation of early-phase [<sup>18</sup>F]-florbetaben PET acquisition in clinical routine cases
Sonja Daerr, Matthias Brendel, Christian Zach, et al.
Molecular Imaging and Biology
|
April 22, 2015
(124)I-PET Assessment of Human Sodium Iodide Symporter Reporter Gene Activity for Highly Sensitive In Vivo Monitoring of Teratoma Formation in Mice
Sebastian Lehner, Cajetan Lang, Georgios Kaissis, et al.
Cancers
|
October 14, 2022
Can Radiomics Provide Additional Information in [<sup>18</sup>F]FET-Negative Gliomas?
Katharina von Rohr, Marcus Unterrainer, Adrien Holzgreve, et al.
Diagnostics (Basel, Switzerland)
|
April 3, 2021
Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on <sup>18</sup>F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression
Lena M Mittlmeier, Stephan T Ledderose, Melanie Schott, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
May 15, 2023
Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria
Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Hemasphere
|
October 3, 2022
Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival
Michael Winkelmann, Kai Rejeski, Viktoria Blumenberg, et al.
Frontiers in Oncology
|
September 26, 2022
Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment
Michael Winkelmann, Veit L Bücklein, Viktoria Blumenberg, et al.
Page
of 55
Search research articles
Search
Showing results (351-360 of 546) with videos related to
Sort By:
Page
of 55
EJNMMI Research
|
August 18, 2017
O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres
Christian P Filss, Nathalie L Albert, Guido Böning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2018
Impact of <sup>68</sup>Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis
Nina-Sophie Schmidt-Hegemann, Chukwuka Eze, Minglun Li, et al.
Frontiers in Neuroscience
|
July 6, 2016
Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches
Adrien Holzgreve, Matthias Brendel, Song Gu, et al.
Neuroimage. Clinical
|
February 1, 2017
Evaluation of early-phase [<sup>18</sup>F]-florbetaben PET acquisition in clinical routine cases
Sonja Daerr, Matthias Brendel, Christian Zach, et al.
Molecular Imaging and Biology
|
April 22, 2015
(124)I-PET Assessment of Human Sodium Iodide Symporter Reporter Gene Activity for Highly Sensitive In Vivo Monitoring of Teratoma Formation in Mice
Sebastian Lehner, Cajetan Lang, Georgios Kaissis, et al.
Cancers
|
October 14, 2022
Can Radiomics Provide Additional Information in [<sup>18</sup>F]FET-Negative Gliomas?
Katharina von Rohr, Marcus Unterrainer, Adrien Holzgreve, et al.
Diagnostics (Basel, Switzerland)
|
April 3, 2021
Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on <sup>18</sup>F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression
Lena M Mittlmeier, Stephan T Ledderose, Melanie Schott, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
May 15, 2023
Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria
Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Hemasphere
|
October 3, 2022
Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival
Michael Winkelmann, Kai Rejeski, Viktoria Blumenberg, et al.
Frontiers in Oncology
|
September 26, 2022
Lymphoma tumor burden before chimeric antigen receptor T-Cell treatment: RECIL vs. Lugano vs. metabolic tumor assessment
Michael Winkelmann, Veit L Bücklein, Viktoria Blumenberg, et al.
Page
of 55